‘Breakthrough’ dementia drug looks to stop disease in its tracks
Filamon Limited, an Australian biotech company focused on developing next-gen anti-inflammatory drugs,…
Filamon Limited, an Australian biotech company focused on developing next-gen anti-inflammatory drugs,…
